Arrr! Nivolumab now sails into the pre-battle waters for lung scallywags! Avast, approval be expanded, me hearties!
2024-10-03
Arrr matey! The mighty checkpoint inhibitor be granted the thumbs up, thanks to the wise folk of CheckMate 77T, fer usin’ it before and after the cutlass in scallywags with resectable NSCLC. Avast, 'tis a right jolly news from the Medscape sea!
Ahoy, mateys! Gather ‘round as I regale ye with a tale from the world o’ medicine, where the brave souls known as scientists be makin’ waves like a ruckus in the high seas! It be news that’d make any scallywag’s heart race—ye see, a fine potion known as a checkpoint inhibitor has earned the approval of the grand council, based on the fabled findings of CheckMate 77T!This wondrous elixir be used in the fiercest battles against the treacherous foe known as non-small cell lung cancer, or NSCLC for those who fancy a bit o’ brevity. Aye, they say this be for those hearty souls who have had their tumors resected, givin’ them a chance to sail the smooth seas of health once more!
In the neoadjuvant and adjuvant realms, this here treatment be a fine ally, preparin’ and supportin’ the brave sailors lookin’ to rid themselves of this vile scourge. So hoist yer sails and raise a tankard for the swashbucklin' scientists who’ve brought forth this boon! For as long as there be pirates on the high seas, there be hope for the ailing! Arrr!